Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728708) titled 'Effects of Axatilimab on Skin in Chronic Graft-versus-Host Disease' on July 22.
Study Type: Observational
Primary Sponsor: Northwestern University
Condition:
Chronic Graft vs. Host Disease
GVHD
cGVHD
Graft Versus Host Disease in Skin
Intervention:
Drug: Axatilimab
Recruitment Status: Not recruiting
Date of First Enrollment: September 2026
Target Sample Size: 15
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07728708
Published by HT Digital Content Services with permission from Health Daily Digest....